YD Bio (YDESW) Payables (2024 - 2026)

YD Bio (YDESW) has reported Payables for 3 consecutive years, with $371594.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 813.84% year-over-year to $371594.0 in Q2 2026; TTM through Jun 2026 was $371594.0, a 813.84% increase from a year earlier, with the FY2025 full-year figure at $413290.0, up 1438.34% from the prior year.
• Payables was $371594.0 for Q2 2026 at YD Bio, down from $413290.0 in the prior quarter.
• Over five years, Payables peaked at $413290.0 in Q4 2025 and troughed at $26866.0 in Q4 2024.
• A 3-year average of $213103.2 and a median of $206128.5 in 2025 frame the typical range for Payables.
• Across the five-year window, Payables surged 1438.34% in 2025 and surged 813.84% in 2026, its largest moves.
• Over 3 years, Payables stood at $26866.0 in 2024, then surged by 1438.34% to $413290.0 in 2025, then dropped by 10.09% to $371594.0 in 2026.
• The last three Payables figures came in at $371594.0 (Q2 2026), $413290.0 (Q4 2025), and $40663.0 (Q2 2025), per Business Quant data.